Class III β-tubulin:: A marker for malignancy in astrocytomas

被引：0
|
作者：
Katsetos, CD
Del Valle, L
Geddes, JF
Assimakopoulou, M
Legido, A
Boyd, JC
Frankfurter, A
de Chadarevian, JP
Maraziotis, T
Varakis, JN
Herman, MM
Khalili, K
机构：
来源：
ANNALS OF NEUROLOGY | 2000年 / 48卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P80
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [1] Aberrant localization of the neuronal class III β-tubulin in astrocytomas -: A marker for anaplastic potential
    Katsetos, CD
    Del Valle, L
    Geddes, JF
    Assimakopoulou, M
    Legido, A
    Boyd, JC
    Balin, B
    Parikh, NA
    Maraziotis, T
    de Chadarevian, JP
    Varakis, JN
    Matsas, R
    Spano, A
    Frankfurter, A
    Herman, MM
    Khalili, K
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2001, 125 (05) : 613 - 624
  • [2] Identification of class III β-tubulin as a marker of angiogenic perivascular cells
    Stapor, Peter C.
    Murfee, Walter L.
    MICROVASCULAR RESEARCH, 2012, 83 (02) : 257 - 262
  • [3] Localization of the neuronal class III β-tubulin in oligodendrogliomas:: A marker for anaplastic potential
    Katsetos, CD
    Geddes, JF
    Del Valle, L
    Legido, A
    Boyd, JC
    Perentes, E
    Mork, SJ
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S110 - S110
  • [4] Class III β-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site
    Seve, Pascal
    Reiman, Tony
    Lai, Raymond
    Hanson, John
    Santos, Cheryl
    Johnson, Lorelei
    Dabbagh, Laith
    Sawyer, Michael
    Dumontet, Charles
    Mackey, John R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 27 - 34
  • [5] Class III β-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site
    Pascal Sève
    Tony Reiman
    Raymond Lai
    John Hanson
    Cheryl Santos
    Lorelei Johnson
    Laith Dabbagh
    Michael Sawyer
    Charles Dumontet
    John R. Mackey
    Cancer Chemotherapy and Pharmacology, 2007, 60
  • [6] TuJ1 (class III β-tubulin) as phenotypic marker of lymphatic and venous valves
    Kang, Jun
    Lee, Inchul
    CARDIOVASCULAR PATHOLOGY, 2006, 15 (04) : 218 - 221
  • [7] Class III β-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia
    Lee, K. M.
    Cao, D.
    Itami, A.
    Pour, P. M.
    Hruban, R. H.
    Maitra, A.
    Ouellette, M. M.
    HISTOPATHOLOGY, 2007, 51 (04) : 539 - 546
  • [8] Class III β-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients
    Ferrandina, G
    Zannoni, GF
    Martinelli, E
    Paglia, A
    Gallotta, V
    Mozzetti, S
    Scambia, G
    Ferlini, C
    CLINICAL CANCER RESEARCH, 2006, 12 (09) : 2774 - 2779
  • [9] Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
    Jun-Eul Hwang
    Ji-Yun Hong
    Karham Kim
    Seung-Hun Kim
    Won-Young Choi
    Min-Jee Kim
    Sung-Hoon Jung
    Hyun-Jeong Shim
    Woo-Kyun Bae
    Eu-Chang Hwang
    Kyung-Hwa Lee
    Jae-Hyuk Lee
    Sang-Hee Cho
    Ik-Joo Chung
    BMC Cancer, 13
  • [10] Class III beta tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients
    Ferrandina, Gabriella
    Ferlini, Cristiano
    Martinelli, Enrica
    Zannoni, Gian Franco
    Legge, Francesco
    Riva, Antonella
    Manzotti, Carla
    Paglia, Amelia
    Scambia, Giovanni
    CANCER RESEARCH, 2006, 66 (08)
12345